| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000027029 |
| Receipt No. | R000030617 |
| Official scientific title of the study | Prevention study of diabetes mellitus by intensive lifestyle modification in gestational diabetes mothers:Daisy M Study |
| Date of disclosure of the study information | 2017/04/17 |
| Last modified on | 2017/06/07 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Prevention study of diabetes mellitus by intensive lifestyle modification in gestational diabetes mothers:Daisy M Study | |
| Title of the study (Brief title) | Daisy M Study | |
| Region |
|
|
| Condition | ||||
| Condition | Women with gestational diabetes mellitus(GDM) | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | YES | |||
| Objectives | |
| Narrative objectives1 | To examine whether a comprehensive lifestyle intervention(diet,exercise,breastfeeding,education)is more effective than a standard lifestyle intervention alone in preventing type 2 diabetes mellitus in women with GDM. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Rate of progression to glucose abnormalities( including impaired fasting glucose (IFG), or impaired glucose tolerance (IGT), or both (IFG, IGT) or type 2 diabetes mellitus(T2DM) 3 month after postpartum |
| Key secondary outcomes | 1. Rate of progression to T2DM 24 months after postpartum
2.Change in blood glucose and serum insulin levels determined by a 75g oral glucose tolerance test (OGTT) 3.Change in body weight from baseline |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Educational,Counseling,Training | ||
| Type of intervention |
|
||
| Interventions/Control_1 | <Comprehensive intensive lifestyle intervention>
The comprehensive intensive lifestyle intervention will include the provision of individual advice on diet and exercise wearing pedometer,education and promoting breastfeeding during pregnancy to 3 months postpartum. Also,nutrients advice will be done by mobile application. Patients diagnosed with diabetes will be withdrawn. |
||
| Interventions/Control_2 | <Standard lifestyle intervention>
The standard lifestyle intervention will include the conventional doet and exercize advic during pregnancy to months postpartum. Patients diagnosed with diabetes will be withdrawn. |
||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Women who:
(1)diagnosed GDM by 75g oral glucose tolerance test at 24 to 32 weeks of gestation in a singleton pregnancy; (a)prepregnancy BMI>=25 or (b)prepregnancy BMI<25 and the presence of 2 or more the following plasma glucose values are exceeded;fasting>=92mg/dl,1h>=180mg/dl,2h>=153mg/dl (2)can participate in the mobile application(only iOS); (3) can respond to the questionnaire in Japanese; (4) are over 18 years of age(are married if they are under the age of 20 years); |
|||
| Key exclusion criteria | (1)a history of diabetes(including overt diabetes in pregnancy);
(2)cardiovascular disease, respiratory disease, etc. with movement limitation before pregnancy; (3)thyroid function that is not controlled by hyperthyroidism; (4)collagen disease, antiphospholipid antibody syndrome, chronic kidney disease, hypertension; (5)pregnancy-induced hypertension, chronic hypertension hypertension before diagnosed GDM; (6)require hospitalization management with threatened abortion, threatened premature delivery, incompetent cervix, ,cervical length shortening, placenta previa and low-lying placenta; (7)early rupture of membranes; (8)persisting bleeding from the vagina; (9)HIV infection; (10)active tuberculosis ; (11)HTLV-1 carriers ; (12)drug dependence; (13)taking steroids ; (14)diagnosed as a fetus chromosomal abnormality ; (15)diagnosed as cleft lip or palate with multiple fetuses with fetal echo ; (16)intrauterine growth restriction; (17)not considered eligible to participate in this study by the attending doctor due to other reasons. |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Yuji Hiramatsu |
| Organization | Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
|
| Division name | Department of Obstructs & Gynecology |
| Address | 5-1,Shikata,2 chome,Kita,Okayama,700-8558,JAPAN |
| TEL | 086-235-7320 |
| daisymon@ncchd.go.jp | |
| Public contact | |
| Name of contact person | Naoko Arat,Maki Kawasaki |
| Organization | National Center for Child Health and Development, Tokyo, Japan |
| Division name | Maternal Medicine |
| Address | 10-1,Okura,2 chome,Setagaya,Tokyo,157-8538,JAPAN |
| TEL | 03-3416-0181(7011) |
| Homepage URL | |
| daisymon@ncchd.go.jp | |
| Sponsor | |
| Institute | National Center for Child Health and Development, Tokyo, Japan |
| Institute | |
| Department | |
| Funding Source | |
| Organization | AMED |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立成育医療研究センター、大阪府立母子総合医療センター、東京医科歯科大学 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030617 |